Skip to main navigation Skip to search Skip to main content

Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer

Research output: Contribution to journal › Journal article › peer-review

Original languageKorean
JournalEuropean Journal of Cancer
StatePublished - 2015.03.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this